Patent assignee · COMPANY

C4 THERAPEUTICS, INC.

29Patents
29Active
29Granted
52Portfolio score

Filing activity: Nov 9, 2018 → Dec 6, 2024

Most-cited patents

PatentTitleAreaCited byStatus
US10849982B2 C3-carbon linked glutarimide degronimers for target protein degradation Emerging Cross-Sectional Technologies 25 Active
US10660968B2 Spirocyclic degronimers for target protein degradation Emerging Cross-Sectional Technologies 23 Active
US10646575B2 Heterocyclic degronimers for target protein degradation Chemistry; Metallurgy 22 Active
US10905768B1 Heterocyclic degronimers for target protein degradation Chemistry; Metallurgy 21 Active
US11185592B2 Spirocyclic degronimers for target protein degradation Emerging Cross-Sectional Technologies 14 Active
US11584748B2 Spirocyclic compounds Chemistry; Metallurgy 5 Active
US11459335B2 N/O-linked Degrons and Degronimers for protein degradation Physics 4 Active
US11407732B1 Tricyclic degraders of Ikaros and Aiolos Chemistry; Metallurgy 4 Active
US11524949B2 Degraders and Degrons for targeted protein degradation Chemistry; Metallurgy 4 Active
US11401256B2 Dihydroquinolinones for medical treatment Chemistry; Metallurgy 3 Active
US11623929B2 Spirocyclic compounds Chemistry; Metallurgy 3 Active
US11691972B2 Compounds for targeted degradation of BRD9 Chemistry; Metallurgy 3 Active
US11254672B2 Dihydrobenzimidazolones for medical treatment Chemistry; Metallurgy 3 Active
US11802131B2 Glutarimides for medical treatment Chemistry; Metallurgy 2 Active
US11673902B2 Isoindolinone and indazole compounds for the degradation of EGFR Chemistry; Metallurgy 1 Active
US11787802B2 Dihydrobenzimidazolones for medical treatment Chemistry; Metallurgy 1 Active
US12048747B2 Substituted piperidine Degronimers for Target Protein degradation Emerging Cross-Sectional Technologies 1 Active
US12091397B2 Dihydroquinolinones for medical treatment Chemistry; Metallurgy 0 Active
US12365681B2 Dihydrobenzimidazolones for medical treatment Chemistry; Metallurgy 0 Active
US12180225B2 N/O-linked degrons and degronimers for protein degradation Physics 0 Active
US12421220B2 Bicyclic-substituted glutarimide cereblon binders Chemistry; Metallurgy 0 Active
US12076405B2 Heterocyclic degronimers for target protein degradation Chemistry; Metallurgy 0 Active
US12227504B2 Spirocyclic compounds Chemistry; Metallurgy 0 Active
US11992531B2 C3-carbon linked glutarimide degronimers for target protein degradation Emerging Cross-Sectional Technologies 0 Active
US12049464B2 Compounds for targeted degradation of BRD9 Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.